The US Food and Drug Administration (FDA) has approved a supplemental new drug application allowing esketamine nasal spray (Spravato; Johnson & Johnson) to be used as a standalone treatment in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback